ProShares Ultra Nasdaq Biotechnolog... (BIB)

$60.65

+0.44 (+0.73%)
Rating:
Recommendation:
-
Symbol BIB
Price $60.65
Beta 0.000
Volume Avg. 0.03M
Market Cap 225.820M
Shares () -
52 Week Range 38.42-67.31
1y Target Est -
DCF Unlevered BIB DCF ->
DCF Levered BIB LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BIB news


None
NASDAQ Global Market

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.